Gilead Sciences, Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Gilead Sciences with three other
pharmaceutical manufacturers in North America:
DuPont de Nemours Inc
sales of $20.40 billion
of which 30%
was Nutrition & Biosciences),
of which 26%
was Other products), and
Eli Lilly and Company
of which 29%
was Oncology-Verzenio & Other).
Gilead Sciences reported sales of $24.69 billion
December of 2020.
increase of 10.0%
versus 2019, when the company's sales were $22.45 billion.